Combined-modality therapy for esophageal and gastroesophageal junction cancers

Current Oncology Reports

Volumn 9, Issue 3, 2007, Pages 184-192

  Yoon, Harry H ^b   Gibson, Michael K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL;

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; HUMAN; LOWER ESOPHAGUS SPHINCTER; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PREOPERATIVE CARE; REVIEW; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FLUOROURACIL; HUMANS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS;

EID: 34248326418     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-007-0020-5     Document Type: Review

References (37)

1. Posner MC, Forastier AA, Minsk BD: Cancer of the esophagus. In Cancer: Principles and Practice of Oncology, edn 7. Edited by DeVita VTH, Rosenberg SA. Philadelphia: Lippincott Williams & Wilkins; 2005:861-909.
2. Arnott SJ, Duncan W, Gignoux M, et al.: Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 2005, 4:CD001799.
3. Daly JM, Karnell LH, Menck HR: National Cancer Data Base report on esophageal carcinoma. Cancer 1996, 78:1820-1828.
4. Herskovic A, Martz K, al-Sarraf M, et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-1598.
5. Cooper JS, Guo MD, Herskovic A, et al.: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999, 281:1623-1627.
6. Chiu PW, Chan AC, Leung SF, et al.: Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005, 9:794-802.
7. Malthaner RA, Collin S, Fenlon D: Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev 2006, 3:CD001556.
8. Medical Research Council Oesophageal Cancer Working Party: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002, 359:1727-1733.
9. Kelsen DP, Ginsberg R, Pajak TF, et al.: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998, 339:1979-1984.
10. Nygaard K, Hagen S, Hansen HS, et al.: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of preoperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992, 16:1104-1109.
11. Ancona E, Ruol A, Santi S, et al.: Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001, 91:2165-2174.
12. Kok TC, v. Lanschot J, Siersema PD, et al.: Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial [abstract]. Proc ASCO 1997, 16:277.
13. Cunningham D, Allum WH, Stenning SP, et al.: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355:11-20.
14. Roth JA, Pass HI, Flanagan MM, et al.: Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988, 96:242-248.
15. Schlag PM: Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg 1992, 127:1446-1450.
16. Law S, Kwong DLW, Tung HM, et al.: Preoperative chemoradiation for squamous cell esophageal cancer: a prospective randomized trial [abstract]. Can J Gastroenterol 1998, 12(Suppl B):161.
17. Maipang T, Vasinanukorn P, Petpichetchian C, et al.: Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 1994, 56:191-197.
18. Bosset JF, Gignoux M, Triboulet JP, et al.: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997, 337:16-1671.
19. Urba SG, Orringer MB, Turrisi A, et al.: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001, 19:305-313.
20. Le Prise E, Etienne PL, Meunier B, et al.: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994, 73:1779-1784.
21. Burmeister BH, Smithers BM, Gebski V, et al.: Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005, 6:659-668.
22. Walsh TN, Noonan N, Hollywood D, et al.: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N EngI J Med 1996, 335:462-467.
23. Tepper, J, Krasna, M, Niedzwiecki, D, et al.: Superiority of trimodality therapy to surgery alone in esophageal cancer: Results of CALGB 9781 [abstract]. J Clin Oncol Proc ASCO 2006, 24:181s.
24. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994, 41:391-393.
25. Walsh TN., MC, Mulligan ED, et al.: Multimodal therapy versus surgery alone for squamous cell carcinoma of the esophagus: a prospective randomized trial [abstract]. Gastroenterology 2000, 118(Suppl 2):1008.
26. Fiorica F, Di Bona D, Schepis F, et al.: Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004, 53:925-930.
27. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185:538-543.
28. Goode EL, Ulrich CM, Potter JD: Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 2002, 11:1513-1530.
29. Rohatgi PR, Swisher SG, Correa AM, et al.: Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 2005, 104:1349-1355.
30. Berger AC, Farma J, Scott WJ, et al.: Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005, 23:4330-4337.
31. Heath EI, Burtness BA, Heitmiller RF, et al.: Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000, 18:868-876.
32. Kleinberg L, Knisely JP, Heitmiller R, et al.: Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2003, 56:328-334.
33. Anne P, Axelrod R, Rosato E, et al.: A phase II trial of preoperative paclitaxel, carboplatin, 5-FU and radiation in patients with resectable esophageal or gastric cancer [abstract]. Proc ASCO 2004, 23:320a.
34. Urba S, Hayman J, Iannettonni M, et al.: Preoperative chemoradiotherapy with cisplatin, 5-FU and paclitaxel followed by surgery and adjuvant chemotherapy, for loco-regional esophageal carcinoma [abstract]. Proc ASCO 2004, 23:319a.
35. Ajani JA, Komaki R, Putnam JB, et al.: A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 2001, 92:279-286.
36. Ajani JA, Walsh G, Komaki R, et al.: Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 2004, 100:2347-2354.
37. Swisher SG, Ajani JA, Komaki R, et al.: Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 2003, 57:120-127.